PERSPECTA

News from every angle

← Back to headlines

RFK Jr.'s Peptide Policy Could Boost Hims & Hers GLP-1 Business

RFK Jr.'s peptide policy could provide a growth opportunity for Hims & Hers as its GLP-1 business evolves, with an FDA review expected in 2026.

16 Apr, 17:44 — 16 Apr, 17:44
PostShare

Sources

Showing 1 of 1 sources
cnbcMostly Factual139d ago

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.

Read full article →

Related Stories

Global Energy Prices Surge Amid Supply Chain Strains and Conflict

23m ago

PG&E Defers $2 Billion in Spending Following Wildfire Bill Setback

32m ago

GE Vernova Signs Agreement to Repair Venezuela’s Power Grid

34m ago

Daily News and Photography Digest Aggregates Global Headlines for September 2, 2026

35m ago